Walden Group Healthcare M&A Blog

  • Bristol-Myers Squibb buying Celgene for $74b

    1/3/2019
    Bristol-Myers Squibb Company, a $20.8b global biopharma company is buying Celgene Corporation, a $13b developer of therapies for cancer and inflammatory diseases. The Deal strengthens Bristol-Myers in oncology, cardiovascular disease, immunology and inflammation. Celgene is known for its blockbuster Thalomid and Revlimid cancer drugs. The...
    Read More
  • GlaxoSmithKline to Acquire Tesaro for $5.1b

    12/3/2018
    GlaxoSmithKline plc (GSK), a large European-based pharmaceutical manufacturer is acquiring TESARO Inc., an oncology-focused biopharmaceutical company. The transaction accelerates GSK's commercial capability in oncology. TESARO's major marketed product is Zejula (niraparib), an oral, once-daily ribose polymerase (PARP) inhibitor approved for use...
    Read More
  • Colfax to Acquire DJO Global for $3.15b

    11/20/2018
    Colfax Corporation, a $3.6b diversified maker of fluid handling and other engineered products is acquiring DJO Global Inc, a leading maker of orthopedic bracing and other non-invasive rehab devcies. The deal diversifies CFX' revenue streams and end-market exposure, reduces cyclicality, weights healthcare and creates a new growth platform for CFX....
    Read More
  • With $1.6B Mazor Robotics Buy, Medtronic Spine is All-in

    10/22/2018
    Medtronic Plc (NYSE:MDT), agreed to buy Mazor Robotics Ltd. (NASDAQ:MZOR), a maker of robotic guidance systems, for $1.64bto strengthen its position in spine surgery. Medtronic’s spine division had been hit off-stride after the problems encountered with Kyphon purchase in 2007. Sales force flux, off-label use of a controversial biologics...
    Read More
  • CVS-Aetna Merger Accelerates Healthcare's Transformation

    10/17/2018
    The Justice Department recently approved CVS’s mega $69b purchase of Aetna, conditioned on Aetna’s sell-off of its private Medicare drug plans. In addition to owning almost 10,000 retail stores in the U.S., CVS provides drug plans to more than 90 million people. It plans to use its pharmacy locations to provide consumers with more local care...
    Read More
  • Page 1 of 1112345...10...Last »